Zeto receives FDA approval for New Wave EEG system
Zeto has acquired 510(okay) clearance from the U.S. Meals and Drug Administration (FDA) for its New Wave electroencephalogram (EEG) system, marking its third FDA-approved machine.
This outpatient EEG system is meant for outpatient clinics and residential care suppliers.
Uncover B2B advertising that delivers
Mix enterprise intelligence and editorial excellence to succeed in engaged professionals throughout 36 main media platforms.
Extra data
The approval permits sooner and simpler testing of sufferers, supporting the necessity for well timed neurodiagnostic insights.
Zeto New Wave is designed as a complete, easy-to-use routine EEG resolution.
The system options 21 soft-tip electrodes positioned in a ten–20 system for full head protection. It features a compact recording machine with built-in show and controls and presents synchronized video and audio recording.
Extra options embrace an elective ECG, electrooculogram (EOG), electromyogram (EMG), built-in orientation sensors, exterior set off inputs for event-related potentials, and photic stimulation detection.
The machine helps short-term EEG recordings of as much as 2.5 hours, making certain clinics can ship well timed care.
Florian Strelzyk, CEO of Zeto, mentioned: “New Wave is our latest outpatient EEG system, constructed on the teachings realized from our first-generation machine, the Zeto WR19. We listened to the wants of neurologists and designed a system that helps clinics broaden entry to EEG, handle staffing points and enhance the affected person expertise.
“In 2024, we launched the ONE particularly for ICUs, emergency rooms and affected person transport, and now with New Wave we have now tailor-made a super resolution for doctor practices. Each methods run on our Zeto Cloud platform and allow distant entry from anyplace. Now suppliers can select which system most closely fits their wants and funds.”
Zeto presents EEG options for intensive care, medical trials, tutorial analysis and outpatient use, with AI help for seizure detection and quantitative analyses. The corporate’s FDA-approved EEG platforms are commercially out there within the US.
In September 2024, Zeto partnered with Firefly Neuroscience to distribute its US FDA-approved EEG headsets.
